Moncayo Roy, Kroiss Alexander, Oberwinkler Manfred, Karakolcu Fatih, Starzinger Matthias, Kapelari Klaus, Talasz Heribert, Moncayo Helga
WOMED, Karl-Kapferer-Strasse 5, Innsbruck, Austria.
BMC Endocr Disord. 2008 Jan 25;8:2. doi: 10.1186/1472-6823-8-2.
Thyroid physiology is closely related to oxidative changes. The aim of this controlled study was to evaluate the levels of nutritional anti-oxidants such as vitamin C, zinc (Zn) and selenium (Se), and to investigate any association of them with parameters of thyroid function and pathology including benign and malignant thyroid diseases.
This controlled evaluation of Se included a total of 1401 subjects (1186 adults and 215 children) distributed as follows: control group (n = 687), benign thyroid disease (85 children and 465 adults); malignant thyroid disease (2 children and 79 adults). Clinical evaluation of patients with benign thyroid disease included sonography, scintigraphy, as well as the determination of fT3, fT4, TSH, thyroid antibodies levels, Se, Zn, and vitamin C. Besides the routine oncological parameters (TG, TSH, fT4, ultrasound) Se was also determined in the cases of malignant disease. The local control groups for the evaluation of Se levels were taken from a general practice (WOMED) as well as from healthy active athletes. Blood samples were collected between 8:00 and 10:30 a.m. All patients lived in Innsbruck. Statistical analysis was done using SPSS 14.0. The Ho stated that there should be no differences in the levels of antioxidants between controls and thyroid disease patients.
Among the thyroid disease patients neither vitamin C, nor Zn nor Se correlated with any of the following parameters: age, sex, BMI, body weight, thyroid scintigraphy, ultrasound pattern, thyroid function, or thyroid antibodies. The proportion of patients with benign thyroid diseases having analyte concentrations below external reference cut off levels were 8.7% of cases for vitamin C; 7.8% for Zn, and 20.3% for Se. Low Se levels in the control group were found in 12%. Se levels were significantly decreased in cases of sub-acute and silent thyroiditis (66.4 +/- 23.1 microg/l and 59.3 +/- 20.1 microg/l, respectively) as well as in follicular and papillary thyroid carcinoma. The mean Se level in the control group was 90.5 +/- 20.8 microg/l.
The H0 can be accepted for vitamin C and zinc levels whereas it has to be rejected for Se. Patients with benign or malignant thyroid diseases can present low Se levels as compared to controls. Low levels of vitamin C were found in all subgroups of patients.
甲状腺生理与氧化变化密切相关。本对照研究的目的是评估营养抗氧化剂如维生素C、锌(Zn)和硒(Se)的水平,并研究它们与甲状腺功能和病理参数(包括良性和恶性甲状腺疾病)之间的任何关联。
对硒的本次对照评估共纳入1401名受试者(1186名成年人和215名儿童),分布如下:对照组(n = 687)、良性甲状腺疾病组(85名儿童和465名成年人);恶性甲状腺疾病组(2名儿童和79名成年人)。对良性甲状腺疾病患者的临床评估包括超声检查、闪烁扫描,以及游离三碘甲状腺原氨酸(fT3)、游离甲状腺素(fT4)、促甲状腺激素(TSH)、甲状腺抗体水平、硒、锌和维生素C的测定。除了常规肿瘤学参数(甲状腺球蛋白(TG)、TSH、fT4、超声)外,在恶性疾病病例中也测定了硒。评估硒水平的局部对照组取自普通诊所(WOMED)以及健康的现役运动员。上午8:00至10:30采集血样。所有患者均居住在因斯布鲁克。使用SPSS 14.0进行统计分析。原假设(H0)指出对照组和甲状腺疾病患者之间抗氧化剂水平不应存在差异。
在甲状腺疾病患者中,维生素C、锌和硒均与以下任何参数无相关性:年龄、性别、体重指数(BMI)、体重、甲状腺闪烁扫描、超声图像、甲状腺功能或甲状腺抗体。良性甲状腺疾病患者中分析物浓度低于外部参考截断水平的比例分别为:维生素C为8.7%的病例;锌为7.8%;硒为20.3%。对照组中12%的人硒水平较低。亚急性和寂静性甲状腺炎病例(分别为66.4±23.1微克/升和59.3±20.1微克/升)以及滤泡状和乳头状甲状腺癌患者的硒水平显著降低。对照组的平均硒水平为90.5±20.8微克/升。
维生素C和锌水平可接受原假设,而硒水平的原假设必须被拒绝。与对照组相比,良性或恶性甲状腺疾病患者的硒水平可能较低。在所有患者亚组中均发现维生素C水平较低。